FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2002 MEDTOX SCIENTIFIC, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-11394 95-3863205 (Commission File Number) (IRS Employer Identification No.) 402 West County Road D St. Paul, Minnesota 55112 (Address of principal executive offices) (Zip Code) (651) 636-7466 (Registrant's telephone number, including area code) Item 5. Other Events. On June 13, 2002, the Company announced that the United States Patent and Trademark Office granted a business method patent to the Company for its on-site drug testing method as described in the press release attached as Exhibit 99.1. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MEDTOX Scientific, Inc. Date: June 13, 2002 By: /s/ Richard J. Braun ------------------------- Name: Richard J. Braun Title: Chief Executive Officer